Articles by Disease (Autoimmune Diseases)

CCR1 Chemokine Receptor Antagonist

Journal: Current Pharmaceutical Design
Volume: 9
Page: 1201-1208
Author(s): Toshihiko Saeki and Akira Naya

The Neuropeptides VIP / PACAP and T Cells: Inhibitors or Activators?

Journal: Current Pharmaceutical Design
Volume: 9
Page: 997-1004
Author(s): Doina Ganea and Mario Delgado

Vitamin D Receptor as a Drug Discovery Target

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 3
Page: 193-204
Author(s): Karen V. Pinette, Ying K. Yee, Bernard Y. Amegadzie and Sunil Nagpal

Cytokine Gene Polymorphism in Heart Transplantation: A Review

Journal: Current Genomics
Volume: 4
Page: 205-215
Author(s): F. J. Bijlsma, A. H. Bruggink, F. H.J. Gmelig-Meyling and R.A. de Weger

Potential Use of Drugs that Target Neural-Immune Pathways in the Treatment of Rheumatoid Arthritis and Other Autoimmune Diseases

Journal: Current Drug Targets - Inflammation & Allergy
Volume: 2
Page: 1-30
Author(s): D. Lorton, C. Lubahn and D. L. Bellinger

The Study of HLA Class II and Autoimmune Diabetes

Journal: Current Molecular Medicine
Volume: 3
Page: 1-15
Author(s): F. Susan Wong and Li Wen

Immune Modulation by Plasmid DNA-mediated Cytokine Gene Transfer

Journal: Current Pharmaceutical Design
Volume: 9
Page: 83-94
Author(s): Ciriaco A. Piccirillo and Gerald J. Prud'homme

Natural Killer T Cells as Targets for Therapeutic Intervention in Autoimmune Diseases

Journal: Current Pharmaceutical Design
Volume: 9
Page: 201-220
Author(s): M. T. Wilson and L. Van. Kaer

Dendritic Cell Homeostasis in the Regulation of Self-Reactivity

Journal: Current Pharmaceutical Design
Volume: 9
Page: 221-231
Author(s): Burkhard Ludewig, Philippe Krebs, Tobias Junt and Gennady Bocharov

Regulation of Self-Reactive T Cells by Human Immunoglobulins- Implications for Multiple Sclerosis Therapy

Journal: Current Pharmaceutical Design
Volume: 9
Page: 245-256
Author(s): Orhan Aktas and Frauke Zipp